Cargando…
Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
The present study aims to design and optimize the lornoxicam dispersible tablet (LXDT) formulation using the Quality by design (QbD) approach. A randomized Box–Behnken experimental design was used to characterize the effect of the critical factors, such as filler (MCC/Mannitol) ratio, mixing time, a...
Autores principales: | Almotairi, Nawaf, Mahrous, Gamal M., Al-suwayeh, Saleh, Kazi, Mohsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785951/ https://www.ncbi.nlm.nih.gov/pubmed/36558914 http://dx.doi.org/10.3390/ph15121463 |
Ejemplares similares
-
Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets
por: Farooqi, Sadaf, et al.
Publicado: (2020) -
Design and dermatokinetic appraisal of lornoxicam-loaded ultrafine self-nanoemulsion hydrogel for the management of inflammation: In vitro and in vivo studies
por: Al-Suwayeh, Saleh A., et al.
Publicado: (2023) -
Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach
por: Dobó, Dorina Gabriella, et al.
Publicado: (2022) -
Industrial application of QbD and NIR chemometric models in quality improvement of immediate release tablets
por: Ramadan, Ahmed, et al.
Publicado: (2021) -
A QbD Approach to Design and to Optimize the Self-Emulsifying Resveratrol–Phospholipid Complex to Enhance Drug Bioavailability through Lymphatic Transport
por: Gausuzzaman, Syed Abul Layes, et al.
Publicado: (2022)